Due diligence to verify the status of a company’s intellectual property is indispensible in the context of mergers, acquisitions, divestitures, joint ventures and IPOs. Alex Denoon has extensive experience in conducting due diligence assessments gained both as General Counsel and at a ‘Magic Circle’ law firm. In this regard, we also have experience assessing and commenting on intellectual property strategies and procedures.

We also have experience advising in relation to the regulatory aspects of a variety of life sciences deals - including established pharmaceutical companies, diagnostic companies, medical device companies, OTC products, prescription only products, manufacturing facilities and clinics.

Where intellectual property rights or regulatory issues are critical to the transaction, we have been intimately involved in the development of novel structures and strategies to address these specific concerns.

As a small, specialised firm we are in an ideal position to assist other law firms with intellectual property due diligence in life science sector deals.